Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial.
Dongiovanni V, Buffoni L, Berruti A, Dongiovanni D, Grillo R, Barone C, Addeo A, Fissore C, Bertetto O. Dongiovanni V, et al. Among authors: bertetto o. Cancer Chemother Pharmacol. 2006 Aug;58(2):203-9. doi: 10.1007/s00280-005-0157-6. Epub 2005 Dec 6. Cancer Chemother Pharmacol. 2006. PMID: 16331497 Clinical Trial.
Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study.
Dongiovanni D, Fissore C, Berruti A, Buffoni L, Addeo A, Barone C, Polimeni MA, Ottaviani D, Bertetto O, Dongiovanni V. Dongiovanni D, et al. Among authors: bertetto o. Lung Cancer. 2005 Feb;47(2):269-75. doi: 10.1016/j.lungcan.2004.06.019. Lung Cancer. 2005. PMID: 15639726 Clinical Trial.
Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: phase II trial.
Buffoni L, Dongiovanni D, Barone C, Fissore C, Ottaviani D, Dongiovanni V, Grillo R, Salvadori A, Birocco N, Schena M, Bertetto O. Buffoni L, et al. Among authors: bertetto o. Lung Cancer. 2006 Dec;54(3):353-7. doi: 10.1016/j.lungcan.2006.08.013. Epub 2006 Oct 17. Lung Cancer. 2006. PMID: 17049672 Clinical Trial.
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial.
Donadio M, Manzin E, Berruti A, Bottini A, Gorzegno G, Danese S, DeFabiani E, Sarobba MG, Lorusso V, Castiglione F, Moro G, Bertetto O, Bumma C, Dogliotti L. Donadio M, et al. Among authors: bertetto o. Cancer Chemother Pharmacol. 2001 May;47(5):391-6. doi: 10.1007/s002800000247. Cancer Chemother Pharmacol. 2001. PMID: 11391853 Clinical Trial.
Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
Schena M, Barone C, Birocco N, Dongiovanni D, Numico G, Colantonio I, Bertetto O. Schena M, et al. Among authors: bertetto o. Cancer Chemother Pharmacol. 2005 Mar;55(3):271-6. doi: 10.1007/s00280-004-0875-1. Epub 2004 Nov 16. Cancer Chemother Pharmacol. 2005. PMID: 15592837 Clinical Trial.
Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients.
Berruti A, Bitossi R, Bottini A, Bonardi S, Donadio M, Nigro C, Bertetto O, Danese S, Bertone E, Sarobba MG, Farris A, Katsaros D, Castiglione F, Volpe T, Lattuada S, Mancarella S, Dogliotti L. Berruti A, et al. Among authors: bertetto o. Eur J Cancer. 2005 Jan;41(2):249-55. doi: 10.1016/j.ejca.2004.07.003. Eur J Cancer. 2005. PMID: 15661550 Clinical Trial.
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up.
Berruti A, Fara E, Tucci M, Tarabuzzi R, Mosca A, Terrone C, Gorzegno G, Fasolis G, Tampellini M, Porpiglia F, De Stefanis M, Fontana D, Bertetto O, Dogliotti L; Gruppo Onco-Urologico Piemontese, Rete Oncologica Piemontese. Berruti A, et al. Among authors: bertetto o. Urol Oncol. 2005 Jan-Feb;23(1):1-7. doi: 10.1016/j.urolonc.2004.06.003. Urol Oncol. 2005. PMID: 15885575 Clinical Trial.
Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer.
Chiappino I, Destefanis P, Addeo A, Galetto A, Cucchiarale G, Munoz F, Zitella A, Ferrando U, Fontana D, Ricardi U, Tizzani A, Bertetto O. Chiappino I, et al. Among authors: bertetto o. Am J Clin Oncol. 2007 Jun;30(3):234-8. doi: 10.1097/01.coc.0000256706.16313.49. Am J Clin Oncol. 2007. PMID: 17551298 Clinical Trial.
108 results